Abiomed

Developing ground-breaking technologies designed to assist or replace the life-sustaining pumping function of the failing heart.

Abiomed (NASDAQ: ABMD) is a pioneer and global leader in healthcare technology and innovation, focused on developing ground-breaking technologies designed to assist or replace the life-sustaining pumping function of the failing heart.

Its main product, the IMPELLA, which is a minimally invasive ventricle assist device, was obtained through the acquisition of Impella Cardiosystems in 2005.

Sale of listed shares in 2008.